3B Pharmaceuticals GmbH products

3B Pharmaceuticals have built a drug discovery platform extending from hit identification to early clinical development. Several drug candidates developed through our platform already have been successfully administered to humans.

Discovery and preclinical development of peptide drug candidates have been 3BP’s core competencies since the company’s inception.

Accurate determination of plasma protein binding (PPB) has been a challenge for many years as a decent fraction of compounds from different classes such as: Peptides and peptidometics, Oligonucleic acids, Small molecules.